LBA23 ABIGAIL: Randomized phase II study of abemaciclib plus endocrine therapy (ET) with or without a short course of induction paclitaxel in patients (pts) with previously untreat... von de la Haba Rodriguez, J., Cortés, J., Di Cosimo, S., Blancas López-Barajas, I., Cortez Castedo, S.P., López, A., López-Miranda, E., Pla Juher, H., Albacar Miro, C.R., Ponce, J., Carañana Ballerini, V., Paris Bouzas, L., Valero Arbizu, M., Ruiz Borrego, M.R.B., Iranzo, V., Garrido, A., Alcalá-López, D., Mina, L., Garcia Mosquera, J.J., Llombart Cussac, A.

Volltext

148P Descriptive study of mutation status and clinical phenotype in breast cancer patients of South Catalonia von Cochs, A., Rodriguez Balada, M., Roig Bourgine, B., Fernández Castillejo, S., Albacar Miro, C.R., Delamo Palomares, L., Querol Garcia, M., Salvat Casas, M., Repkova, J., Masvidal Hernandez, M., Serrano Solares, S., Amillano Parraga, K., Mele Olive, M., Gumà, J.

Volltext

93MO Optimal 18F-FDG PET/CT (FDG-PET) cut-off for pathological complete response (pCR) prediction in HER2-positive [HER2+] early breast cancer (EBC) patients (pts) treated with neo... von Gebhart, G., Keyaerts, M., Guiot, T., Flamen, P., Ruiz Borrego, M., Stradella, A., Bermejo De Las Heras, B., Escriva de Romani, S., Calvo-Martinez, L., Ribelles Entrena, N., Martinez, N., Albacar Miro, C.R., Colleoni, M.A., Atienza de Frutos, M., Sampayo-Cordero, M., Cortés, J., Perez Garcia, J.M., Llombart Cussac, A.

Volltext

197P ATREZZO trial (SOLTI-1907): A phase II trial targeting estrogen receptor negative or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbin... von Ciruelos, E.M., Ortega, P. Tolosa, Bofill, F.J. Salvador, González-Santiago, S., Miro, C.R. Albacar, Escrivá-De-Romaní, S., Gonzalez, A. Lopez, Simon, S. Pernas, Ponce, J., Martínez-Sáez, O., Cejalvo, J.M., Martorell, A. Perello, López-Barajas, I. Blancas, Guerra, J.A., Torres, E. Sanfeliu, Sanchez, C.A. Rodríguez, Villanueva, L., Villacampa, G., Prat, A., Pascual, T.

Volltext